Table 2.
Patient characteristics | High adherence (n=65) | Medium/low adherence (n=165) | p-value |
---|---|---|---|
Age, years, median [IQR] | 61 [57–69] | 53 [38–64] | <0.001 |
Unemployed, % | 19 | 8 | 0.01 |
Disability, % | 2 | 9 | 0.04 |
Married/live with a partner, % | 83 | 66 | 0.01 |
≥20 years living in the US, % | 62 | 41 | 0.005 |
Immigration age, years, mean (SD) | 42 (14) | 35 (13) | 0.001 |
Medication Regimen Complexity, median [IQR] | 14 [10–19] | 10 [7–15] | <0.001 |
Rheumatic Medication Regimen Complexity, median [IQR] | 8 [6–12] | 7 [5–10] | 0.01 |
Traditional Chinese medicine use, % | 65 | 44 | 0.005 |
Sleep disturbance, median T-score [IQR] | 49 [42–53] | 53 [45–56] | 0.02 |
Cognitive general concerns, median T-score [IQR] | 33 [26–38] | 37 [30–40] | 0.04 |
Anxiety, median T-score [IQR] | 43 [36–55] | 52 [42–57] | 0.02 |
Depression, median T-score [IQR] | 43 [37–55] | 50 [37–57] | 0.09 |
Pain interference, median T-score [IQR] | 57 [50–63] | 57 [52–63] | 0.8 |
Fatigue, mean T-score (SD) | 50 (10) | 52 (10) | 0.07 |
Physical function, median T-score [IQR] | 42 [37–52] | 45 [39–52] | 0.11 |
Ability to Participate in SRAs, median T-score [IQR] | 60 [52–62] | 58 [51–66] | 0.7 |
Instrumental support, median T-score [IQR] | 51 [47–56] | 47 [45–51] | 0.007 |
IQR = interquartile range; SD = standard deviation; SRA = social roles and activities